Literature DB >> 6411742

Interactions of a mammalian beta-galactoside-binding lectin with hamster fibroblasts.

D Stojanovic, R C Hughes, T Feizi, R A Childs.   

Abstract

A beta-galactoside-binding endogenous lectin extracted from bovine heart binds to the surface of baby hamster kidney (BHK) cells. The binding to and agglutination of cells is reduced in certain ricin-resistant mutants (Ric cells) in parallel with the decreased number of binding sites for the selective agent, ricin, a galactose-specific plant lectin. However, clear differences in the binding specificities of bovine lectin and ricin are shown by the effect of neuraminidase. BHK cells and Ric mutant cells treated with neuraminidase bind similar amounts of the bovine lectin compared with untreated cells, and ricin binding is greatly increased. The mammalian lectin immobilised on inert glass mediates the attachment and spreading of normal BHK cells and agglutinates these cells in solution. Ricin-resistant mutant cells respond poorly. These results are consistent with a role of endogenous lectins in cellular adhesiveness and show that cell adhesion may be regulated by the density of specific surface receptors for lectins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411742     DOI: 10.1002/jcb.240210203

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

Review 1.  Plant as a plenteous reserve of lectin.

Authors:  A G Ingale; A U Hivrale
Journal:  Plant Signal Behav       Date:  2013-10-01

Review 2.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

3.  Production and characterization of monoclonal antibodies to beta-galactoside-binding lectin of bovine heart muscle. Direct evidence that haemagglutinating activity is associated with a 13kDa protein.

Authors:  S R Carding; R Thorpe; R A Childs; M Spitz; T Feizi
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.